Dr. Timothy Hughes Compares Imatinib to Nilotinib in Chronic Myeloid Leukemia
0 Views
administrator
07/08/23
Timothy P. Hughes, MD, MBBS, Royal Adelaide Hospital, Adelaide, Australia, explains the two-year follow-up results of the Enestcmr trial analyzing the switch to nilotinib after at least 2 years on imatinib in patients with chronic phase chronic myeloid leukemia.
For more resources, visit: http://www.onclive.com/special....ty/hematologic-cance
-
Category
Show more
Facebook Comments
No comments found